Cholesterol Derivative Synthesis from Phytosterols with Easier Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing cholesterol and its derivatives face challenges such as low yield, high purification difficulty, limited raw material sources, safety risks, and supply limitations, particularly in the extraction from animal materials and semi-synthesis from plant raw materials.
Innovation Solution
A method involving two approaches to construct AB rings and side chains for preparing compounds represented by formula III, using sodium borohydride and calcium chloride in the presence of specific protecting groups and reagents to achieve chiral selective obtaining or isomer separation of cholesterol derivatives like 7-dehydrocholesterol, 25-hydroxycholesterol, and 25-hydroxy-7-dehydrocholesterol.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If extraction from animal materials is used, then cholesterol and its derivatives can be obtained, but the yield is low, purification difficulty is high, and safety risks exist
Solution Approach 1:
The patent extracts the core structural framework of cholesterol from plant sterols (such as stigmasterol or beta-sitosterol) through semi-synthetic conversion, separating the useful chiral skeleton from the problematic animal source materials. This allows obtaining cholesterol derivatives without direct extraction from animal tissues, thereby eliminating safety risks while maintaining production efficiency
Solution Approach 2:
The patent introduces plant sterols as intermediary substances to bridge the gap between available raw materials and target cholesterol products. Through enzymatic or chemical conversion of plant sterols into cholesterol derivatives, the process avoids direct animal material extraction while achieving the desired pharmaceutical compounds with high yield and purity
2Reliability
If semi-synthesis from plant raw materials is used, then safety risks are reduced, but the supply and price of plant raw materials are limited
Solution Approach 1:
The patent modifies the chemical structure of plant sterols through controlled oxidation, reduction, and rearrangement reactions to convert them into cholesterol derivatives. By changing the chemical parameters (functional groups, stereochemistry) of plant sterols, the process expands the可利用 raw material base beyond traditional plant sources, thereby increasing supply while maintaining safety
Solution Approach 2:
The patent establishes a universal conversion pathway where multiple types of plant sterols (stigmasterol, beta-sitosterol, and other phytosterols) can be converted into the same cholesterol derivative products. This multi-functional approach allows the process to utilize diverse plant sources, reducing dependence on any single plant material and enhancing supply reliability
3Productivity
If conventional synthesis methods are used, then cholesterol derivatives can be produced, but the yield is low and purification is difficult
Solution Approach 1:
The patent replaces conventional multi-step chemical synthesis with enzymatic transformation methods. Using specific enzymes (such as cholesterol side-chain cleavage enzyme or sterol 25-hydroxylase) to catalyze the conversion of plant sterols into cholesterol derivatives, the process achieves higher yield and simpler purification compared to traditional chemical methods, while maintaining manufacturing precision
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides a more efficient and controlled synthesis of cholesterol derivatives with improved yield and purity, addressing the limitations of existing methods by optimizing the construction of AB rings and side chains.
Implementation Method 1
Step (B): reducing the compound represented by formula a to a compound represented by formula b under the action of sodium borohydride, calcium chloride and pyridine
Data Source
AI summary
The present invention relates to the field of pharmaceutical chemistry, and specifically to a method for preparing cholesterol, a derivative thereof, and an analog thereof. The derivative of cholesterol comprises, but is not limited to, 7-dehydrocholesterol, 25-hydroxycholesterol, 25-hydroxy-7-dehydrocholesterol, and ergosterol. In the present invention, a compound represented by formula I can be prepared by means of a microbial transformation using phytosterols as a raw material, followed by preparing cholesterol, the derivative thereof, and the analog thereof.